Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: A meta-analysis

JAMA Oncology

Volumn 3, Issue 7, 2017, Pages 961-968

  Mustian, Karen M ^a   Alfano, Catherine M ^b   Heckler, Charles ^a   Kleckner, Amber S ^a   Kleckner, Ian R ^a   Leach, Corinne R ^b   Mohr, David ^c   Palesh, Oxana G ^d   Peppone, Luke J ^a   Piper, Barbara F ^e   Scarpato, John ^f   Smith, Tenbroeck ^b   Sprod, Lisa K ^g   Miller, Suzanne M ^f  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d STANFORD CANCER INSTITUTE   (United States)

^e NATIONAL UNIVERSITY   (United States)

^f FOX CHASE CANCER CENTER   (United States)

^g UNIVERSITY OF NORTH CAROLINA WILMINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARMODAFINIL; DEXMETHYLPHENIDATE; METHYLPHENIDATE; METHYLPREDNISOLONE; MODAFINIL; PAROXETINE; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; GLUCOCORTICOID; SEROTONIN UPTAKE INHIBITOR; WAKEFULNESS PROMOTING AGENT;

ARTICLE; CANCER FATIGUE; CANCER STAGING; COGNITIVE BEHAVIORAL THERAPY; DATA BASE; DISEASE SEVERITY; EFFECT SIZE; EVIDENCE BASED PRACTICE; EXERCISE; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PHYSIOTHERAPY; PSYCHOEDUCATION; PSYCHOTHERAPY; QUALITY OF LIFE; SYSTEMATIC REVIEW; TREATMENT DURATION; COGNITIVE THERAPY; COMPARATIVE STUDY; COMPLICATION; FATIGUE; KINESIOTHERAPY; NEOPLASM;

BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITIVE THERAPY; DEXMETHYLPHENIDATE HYDROCHLORIDE; DEXTROAMPHETAMINE; EXERCISE THERAPY; FATIGUE; GLUCOCORTICOIDS; HUMANS; METHYLPHENIDATE; METHYLPREDNISOLONE; NEOPLASMS; PAROXETINE; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS; WAKEFULNESS-PROMOTING AGENTS;

EID: 85025064257     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2016.6914     Document Type: Article

References (57)

1. Patrick DL, Ferketich SL, Frame PS, et al; National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst. 2003;95(15):1110-1117.
2. Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment. Support Care Cancer. 2008;16(7):791-801.
3. Kuhnt S, Ernst J, Singer S, et al. Fatigue in cancer survivors—prevalence and correlates. Onkologie. 2009;32(6):312-317.
4. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38(1):27-43.
5. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;(32):40-50.
6. Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue. Oncologist. 2007;12(suppl 1):4-10.
7. Minton O, Stone P. How common is fatigue in disease-free breast cancer survivors? Breast Cancer Res Treat. 2008;112(1):5-13.
8. Prue G, Rankin J, Allen J, Gracey J, Cramp F. Cancer-related fatigue: a critical appraisal. Eur J Cancer. 2006;42(7):846-863.
9. Andrykowski MA, Donovan KA, Laronga C, Jacobsen PB. Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer. 2010;116(24):5740-5748.
10. Cella D, Davis K, Breitbart W, Curt G; Fatigue Coalition. Cancer-related fatigue. J Clin Oncol. 2001; 19(14):3385-3391.
11. Bower JE, Ganz PA, Desmond KA, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106(4): 751-758.
12. Carpenter JS, Elam JL, Ridner SH, Carney PH, Cherry GJ, Cucullu HL. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum. 2004;31(3):591-598.
13. Stepanski EJ, Walker MS, Schwartzberg LS, Blakely LJ, Ong JC, Houts AC. The relation of trouble sleeping, depressed mood, pain, and fatigue in patients with cancer. J Clin Sleep Med. 2009;5(2):132-136.
14. Roscoe JA, Kaufman ME, Matteson-Rusby SE, et al. Cancer-related fatigue and sleep disorders. Oncologist. 2007;12(suppl 1):35-42.
15. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors. J Clin Oncol. 2000;18(4):743-753.
16. Alexander S, Minton O, Andrews P, Stone P. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer. 2009;45(3):384-392.
17. Donovan KA, Jacobsen PB. Fatigue, depression, and insomnia. Semin Oncol Nurs. 2007;23(2):127-135.
18. Beck SL, Dudley WN, Barsevick A. Pain, sleep disturbance, and fatigue in patients with cancer. Oncol Nurs Forum. 2005;32(3):542.
19. Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients. Oncologist. 2000;5(5):353-360.
20. Symptom Management and Quality of Life Steering Committee. National Cancer Institute. 2015 Strategic Priorities: Symptom Management and Quality of Life Steering Committee. 2015. https://www.cancer.gov/about-nci/organization/ccct/steering-committees/2015-SxQoLSC-StrategicPriorities. Accessed August 8, 2016.
21. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev. 2009;(1):CD006953.
22. Peuckmann V, Elsner F, Krumm N, Trottenberg P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2010;(11):CD006788.
23. Velthuis MJ, Agasi-Idenburg SC, Aufdemkampe G, Wittink HM. The effect of physical exercise on cancer-related fatigue during cancer treatment. Clin Oncol (R Coll Radiol). 2010;22(3):208-221.
24. Speck RM, Courneya KS, Mâsse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors. J Cancer Surviv. 2010;4(2):87-100.
25. Brown JC, Huedo-Medina TB, Pescatello LS, Pescatello SM, Ferrer RA, Johnson BT. Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors. Cancer Epidemiol Biomarkers Prev. 2011;20(1):123-133.
26. van Vulpen JK, Peeters PH, Velthuis MJ, van der Wall E, May AM. Effects of physical exercise during adjuvant breast cancer treatment on physical and psychosocial dimensions of cancer-related fatigue. Maturitas. 2016;85:104-111.
27. Meneses-Echávez JF, González-Jiménez E, Ramírez-Vélez R. Effects of supervised exercise on cancer-related fatigue in breast cancer survivors. BMC Cancer. 2015;15:77.
28. Meneses-Echavez JF, Gonzalez-Jimenez E, Ramirez-Velez R. Effects of supervised multimodal exercise interventions on cancer-related fatigue. BioMed Res Int. 2015;2015:328636.
29. Puetz TW, Herring MP. Differential effects of exercise on cancer-related fatigue during and following treatment. Am J Prev Med. 2012;43(2):e1-e24.
30. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;11:CD006145.
31. Duijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors. Psychooncology. 2011;20(2):115-126.
32. Jacobsen PB, Donovan KA, Vadaparampil ST, Small BJ. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol. 2007;26(6): 660-667.
33. Du S, Hu L, Dong J, et al. Patient education programs for cancer-related fatigue: a systematic review. Patient Educ Couns. 2015;98(11):1308-1319.
34. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst. 2008;100(16):1155-1166.
35. Gong S, Sheng P, Jin H, et al. Effect of methylphenidate in patients with cancer-related fatigue. PLoS One. 2014;9(1):e84391.
36. Mitchell SA, Hoffman AJ, Clark JC, et al. Putting evidence into practice. Clin J Oncol Nurs. 2014;18 (suppl):38-58.
37. Bower JE, Bak K, Berger A, et al; American Society of Clinical Oncology. Screening, assessment, and management of fatigue in adult survivors of cancer. J Clin Oncol. 2014;32(17):1840-1850.
38. Berger AM, Mooney K, Alvarez-Perez A, et al. NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue. https://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf. 2016. Published December 19, 2016. Accessed February 8, 2017.
39. Moher D, Altman DG, Liberati A, Tetzlaff J. PRISMA statement. Epidemiology. 2011;22(1):128.
40. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269, W264.
41. Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue. Psychol Bull. 2008;134(5): 700-741.
42. Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51(12):1235-1241.
43. Bhogal SK, Teasell RW, Foley NC, Speechley MR. The PEDro scale provides a more comprehensive measure of methodological quality than the Jadad scale in stroke rehabilitation literature. J Clin Epidemiol. 2005;58(7):668-673.
44. Moseley AM, Herbert RD, Sherrington C, Maher CG. Evidence for physiotherapy practice: a survey of the Physiotherapy Evidence Database (PEDro). Aust J Physiother. 2002;48(1):43-49.
45. Hedges LV. A random effects model for effect sizes. Psychol Bull. 1983;93(2):388-395.
46. Higgins JPT, Green S. Cochrane Collaboration: Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: Wiley-Blackwell; 2008.
47. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-analysis. Chichester, England: John Wiley & Sons; 2009.
48. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1-48.
49. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper Fatigue Scale. Oncol Nurs Forum. 1998;25(4):677-684.
50. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients. Cancer. 1999;85(5):1186-1196.
51. Stein KD, Martin SC, Hann DM, Jacobsen PB. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract. 1998;6(3):143-152.
52. FACIT.org. Questionnaires. http://www.facit.org/FACITOrg/Questionnaires. Accessed February 7, 2017.
53. EORTC Quality of Life Department. EORTC QLQ-C30. http://groups.eortc.be/qol/eortc-qlq-c30. Accessed February 7, 2017.
54. Duval S, Tweedie R. The trim and fill method. In: Rothstein HR, Sutton AJ, Borenstein M, eds. Publication Bias in Meta-analysis: Prevention, Assessment and Adjustments. Chichester, England: Wiley; 2005.
55. Rosenberg MS. The file-drawer problem revisited. Evolution. 2005;59(2):464-468.
56. Saint-Raymond A, Hill S, Martines J, Bahl R, Fontaine O, Bero L. CONSORT 2010. Lancet. 2010; 376(9737):229-230.
57. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 Statement. J Clin Epidemiol. 2010;63(8):834-840.